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Abstract
Objective: Endothelial dysfunction associated with systemic inflammation can contribute to organ injury/failure following
cardiac surgery requiring cardiopulmonary bypass (CPB). Roundabout protein 4 (Robo4), an endothelial-expressed
transmembrane receptor and regulator of cell activation, is an important inhibitor of endothelial hyper-permeability. We
investigated the hypothesis that plasma levels of Robo4 are indicative of organ injury, in particular acute kidney injury (AKI),
after cardiac surgery.
Methods: Patients (n = 32) undergoing elective cardiac surgery with CPB were enrolled, prospectively. Plasma Robo4
concentrations were measured pre-, 2 and 24 h post-operatively, using a commercially available ELISA. Plasma and
endothelial markers of inflammation [interleukin (IL) -6, -8, -10: von Willibrand factor (vWF) and angiopoeitin-2 (Ang-2)] and
the AKI marker, neutrophil gelatinase-associated lipocalin (NGAL), were also measured by ELISA.
Results: Plasma Robo4 increased significantly (p,0.001) from pre-operative levels of 25156904 pg/ml to 447361915 pg/
ml, 2 h after surgery; and returned to basal levels (26826979 pg/ml) by 24 h. Plasma cytokines, vWF and NGAL also
increased 2 h post-operatively and remained elevated at 24 h. Ang-2 increased 24 h post-operatively, only. There was a
positive, significant correlation (r = 0.385, p = 0.0298) between Robo-4 and IL-10, but not other cytokines, 2 h post-
operatively. Whilst raised Robo4 did not correlate with indices of lung dysfunction or other biomarkers of endothelial
activation; there was a positive, significant correlation between raised (2 h) plasma NGAL and Robo4 (r = 0.4322, p = 0.0135).
When patients were classed as AKI or non-AKI either using NGAL cut-off of 150 ng/ml, or the AKI Network (AKIN) clinical
classification; plasma Robo4 was significantly higher (p = 0.0073 and 0.003, respectively) in AKI vs. non-AKI patients (NGAL
cut-off: 535062191 ng/ml, n = 16 vs. 359561068 pg/ml, n = 16; AKIN: 6546 pg/ml, IQR 5025–8079, n = 6; vs. 3727 pg/ml, IQR
1962–3727, n = 26) subjects.
Conclusion: Plasma Robo4 levels are increased, transiently, following cardiac surgery requiring CPB; and higher levels in
patients with AKI suggest a link between endothelial dysregulation and onset of AKI.
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Introduction
Activation of the vascular endothelium occurs following cardiac
surgery requiring cardiopulmonary bypass (CPB) [1]; and
contributes to the systemic inflammatory response (SIRS) that
manifest in the majority of such patients post-operatively [2]. In a
highly regulated sequence of events, encompassing increased
coagulant and adhesive states, release of pro-inflammatory
mediators and loss of barrier function; extravasation of excess
fluid leads to tissue oedema and eventually organ dysfunction.
Devastating organ injuries such as acute lung injury (ALI) [3] and
acute kidney injury (AKI) [4,5], are amongst the most frequent
complications of cardiac surgery with CPB. Endothelial biomark-
ers are not measured routinely in the context of cardiac surgery
requiring CPB, but we hypothesised that such measurements
might assist in identifying those most at risk of developing organ
failure and subsequent morbidity and mortality.
SIRS [6], sepsis [7] and infectious diseases [8], are associated
with perturbations in endothelial markers including those relevant
to coagulation, adhesion, vascular tone and permeability. Of these,
von Willebrand factor (vWF) and angiopoeitin-2 (Ang2) have been
the most extensively studied and showed associations with organ
dysfunction, notably ALI [6,8]. Further, a doubling in plasma
vWF that was positively associated with urinary albumin
creatinine ratio was reported following CPB, linking endothelial
injury with increased permeability [9]. More recently, another
study also showed increased vWF after CPB, but associations with
other indices were not sought [10]. Raised Ang-2 levels after CPB,
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in children, correlated with intensive care unit length of stay (ICU
LOS) ([11]; and in adults, with duration of mechanical ventilation,
ICU LOS and mortality [12]).
Roundabout (Robo) proteins are a family of transmembrane
receptors originally identified for their role in axon guidance
during development of the nervous system [13]. Four receptors
have been characterised, of which Robo-1, -2 and -3 share a
common extracellular structure similar to adhesion molecules;
with five immunoglobulin-like (Ig) domains and three fibronectin
type 3 (FN3) repeats [14,15]. The fourth, Robo4 or magic
roundabout protein, is found only in vertebrates and has 2 Ig
domains and 2 FN3 repeats [14,15]. Following initial identification
as an endothelial expressed gene [16], Robo4 was designated a
tumour endothelial marker and its role in endothelial migration
determined [17]. It has since been detected in vascular smooth
muscle [18], hematopoietic stem [19] and rat airway smooth
muscle [20] cells, with functional roles in cell migration also
described.
Robo4 is an important inhibitor of pathologic angiogenesis and
endothelial hyper-permeability, that prevented VEGF-induced
changes in models of retinal and choroidal vascular disease
[21,22]; and hyper-permeability in bacterial and viral models of
sepsis [23]. Robo4 interaction with its ligand Slit2 also prevented
pathological angiogenesis in virus-induced keratitis [24]; HIV-
induced lymphatic hyper-permeability [25]; changes in retinal
endothelial permeability [26]; Andes virus-induced permeability
increases in lung microvascular endothelial cells [27]; and
inhibition of LPS-induced cytokine/chemokine release and
ICAM-1 expression in HUVEC [28]. Also, a novel anti-
inflammatory strategy (apoA-I mimetic 4F) that increased
Robo4/Slit2 expression strengthened vascular barrier function,
protecting kidneys and heart in an animal model of sepsis [29].
To our knowledge, no other study has yet quantified plasma
Robo4 in clinical SIRS. We therefore explored the hypotheses:
first, that Robo4 would be detected and elevated in plasma of
patients following CPB. Second, that raised Robo4 levels would
correlate with changes in established markers of systemic
inflammation and endothelial activation; and finally, that increases
in Robo4 would correspond with markers of organ failure, proving
a useful early predictor of those most at risk of complications, post
cardiac surgery requiring CPB. Indeed, our findings showed that
plasma levels of Robo4 levels were significantly elevated, albeit
transiently, post CPB and were higher in patients deemed to have
AKI.
Methods
Patient population and sample collection
Samples and clinical data were collected from thirty-two
patients recruited sequentially at the Royal Brompton Hospital,
London, UK (December 2008 to August 2009) undergoing surgery
for valve replacement and/or coronary artery bypass grafting
(CABG) and requiring CPB. Exclusion criteria were lack of
informed consent. Blood was collected via indwelling cannulæ; and
if not for immediate analysis, processed and plasma samples stored
at 280uC. Samples were collected immediately prior to surgery
and at 0, 2, 4, 6 and 24 h post-operatively.
Robo4 and inflammatory/endothelial marker assays
Commercially available sandwich enzyme-linked immunosor-
bent assay (ELISA) kits were used to measure: Robo4 (Cusabio
Biotech, Suffolk, UK); IL-6, -8 (Hycult Biotechnology, Uden, The
Netherlands); IL-10 (BD Bioscience, Oxford, UK); NGAL(Bio-
Porto Diagnostics A/S, Hellerup, Denmark); Ang-2 (R&D
Systems, Oxford, U.K.); and vWF (Zymutest vWF kit; Hyphen-
Biomed, Neuville-sur-Oise, France). Biomarkers were measured at
all the time points in: all patients (cytokines/NGAL); or a pilot
study of 3 patients (Robo4, vWF and Ang-2); and subsequently,
pre-, 2 and 24 h post-operatively- a choice dictated by pilot study
data and sample availability.
Clinical data
Pre-operative characteristics, age, gender, Body Mass Index
(BMI), creatinine and a widely employed clinical risk assessment
tool (additive EUROscore) were recorded. Operative (nature of
procedure; and duration from beginning of anaesthesia to end of
CPB) and post-operative variables were obtained following
interrogation of an automated clinical data collection system;
and included post-operative oxygenation (PaO2:FiO2 [PF] ratio),
as an indicator of pulmonary dysfunction (first value recorded on
return to ICU); and duration of mechanical ventilation. Patients
were defined as having AKI or not (non-AKI), using NGAL cut-off
levels of ,or.150 ng/ml [30]; and secondly, using the AKI
Network (AKIN) classification system [4]. Indices of clinical
outcome included duration of level 3 dependency, and ICU and
hospital LOS [2,31]. The former was employed as a composite
index reflecting the degree of physiological derangement and the
requirements for supportive care. The study protocol was
approved by the Research Ethics Committee for the Royal
Brompton and Harefield NHS Foundation Trust and informed
written consent was obtained from all patients.
Statistics
Statistical analyses were performed to establish how plasma
biomarkers were altered following surgery and to investigate
associations with clinical indices. Non-parametric data were
expressed as median and interquartile range (IQR) and compared
using: Wilcoxon matched-pairs test with Dunn’s correction for 2
paired groups and Friedman’s test for 3 paired groups; or Mann-
Whitney U test for 2 unpaired groups. Parametric data were
expressed as mean 6 standard deviation (SD) and compared
using: repeated measures ANOVA and Tukey’s Multiple Com-
parison Test; or Student’s t test for unpaired data. Correlations
between variables were assessed using Spearman analysis (non-
parametric, stating r) or Pearson’s parametric analysis (stating r
and r2), with associated p values. P values of ,0.05 were
considered significant. Excel 2007 (Microsoft, CA) and Prism
v5.04 (Graphpad software, CA) were used for analyses.
Results
Patient characteristics
Demographics, clinical characteristics, operative variables and
post-operative outcomes of the patient population (n= 32) are
shown in Table 1. Median duration of level 3 care required was
33.7 h (IQR, 18.4–69); ICU LOS was 44.3 h (IQR, 23–56.4); and
hospital LOS, 10 days (IQR, 9–12.5). Overall hospital mortality
was 0%.
Plasma levels of Robo4 increased post-cardiac surgery
requiring CPB
Plasma levels of Robo4 were significantly (p,0.001) higher in
patients 2 h post-operatively (447361915 pg/ml) compared with
levels in paired samples taken prior to surgery (25156904 pg/ml);
returning to basal levels by 24 h (26826979 pg/ml; Fig. 1).
Utilising the patient characteristics in Table 1, significant,
positive correlations were found between pre-operative levels of
Robo4 with BMI (r = 0.37, p= 0.038) and EUROScore (r = 0.413,
Robo4 and Acute Kidney Injury
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r2 = 0.1702, p= 0.019). However, there were no significant
differences when patients were divided either into normal,
overweight and obese groups (data not shown); nor of EUROscore
$6 (high risk; 27786724 pg/ml, n= 16) vs ,6 (225361008 pg/
ml, n = 16). When operative variables were considered, no
associations were found with duration of operation (defined here
as induction of anaesthesia to end of CPB). Robo4 levels did not
vary significantly depending on the operative procedure; nor were
associations found with ICU LOS, duration of level 3 Care, or
hospital LOS (data not shown).
Indices of systemic inflammation increased post cardiac
surgery requiring CPB
We have previously utilised raised CRP and IL-8 levels to
confirm post-operative systemic inflammation [31]. Pre-operative
CRP was normal but increased significantly (p,0.0001) by day 1,
post-operatively; as did white cell count (p = 0.0378), but the latter
Table 1. Clinical and biochemical characteristics, operative variables and post-operative outcomes of study patientsa.
Pre-operative characteristics
Age, mean (SD) years 66 (10)
Gender F/M 7/25
Body Mass Index, median (IQR) kg/m2 26.9 (25.1–28.95)
Creatinine mmol/L, mean (SD) 93.22 (24.96)
Operative variables
Operation
CABG alone, n (%) 12 (37.5)
Valve repair/replacement, n (%) 15 (46.9)
CABG plus valve surgery, n (%) 15 (46.9)
Duration from start of anaesthesia to end
bypass, median (IQR) min
216.5 (179–267)
Post-operative outcomes
ICU length of stay, median (IQR) h 44.3 (23–56.4)
Level 3 care duration, median (IQR) h 33.7 (18.4–69)
Hospital length of stay, median (IQR) days 10 (9–12.5)
Hospital mortality, n (%) 0 (0)
an = 32 patients undergoing cardiac surgery requiring cardiopulmonary bypass.
IQR = interquartile range; SD= standard deviation; CABG=Coronary artery bypass grafting; ICU= intensive care unit.
doi:10.1371/journal.pone.0111459.t001
Figure 1. Plasma levels of Robo4 before and after cardiac surgery. Plasma levels of Robo4 increased 2 h post-cardiac surgery requiring
cardiopulmonary bypass compared with pre-operative levels and those 24 h post-surgery. Data are presented as bar graphs with mean and SD
concentrations (pg/ml) of Robo4; n = 32, ***p,0.001 compared with pre- and 24 h levels.
doi:10.1371/journal.pone.0111459.g001
Robo4 and Acute Kidney Injury
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remained within the normal range (Table 2). Cytokine biomarkers
of systemic inflammation showed characteristic plasma profiles
with time; increasing significantly at 2 h and remaining elevated,
albeit at lower levels, 24 h post-operatively (Table 2). Of the
cytokines measured, there was a moderate significant positive
correlation between IL-10 and Robo4 levels, 2 h post-operatively
(r = 0.385, p = 0.0298).
Indices of organ dysfunction/injury following cardiac
surgery requiring CPB
Baseline values of accepted biomarkers of kidney function
(plasma and urine NGAL) and serum creatinine were within
normal range (Table 3). Plasma and urine NGAL levels were
significantly increased (p,0.001) at 2 and 24 h (Table 3). Whilst
there was no association between creatinine (pre or post-
operatively) and Robo4 levels, there were positive associations
between plasma NGAL and Robo4 levels pre- (r = 0.3937,
p = 0.0258) and 2 h post- (r = 0.4322, p = 0.0135) operatively.
There was also a strongly positive, significant association between
urine NGAL levels and plasma Robo4 at 2 h (r = 0.6998, p,
0.0001).
Robo4 was significantly (p = 0.0073) greater in the patient group
with plasma levels of NGAL of .150 ng/ml (535062191 ng/ml,
n = 16), than in the group with NGAL levels ,150 ng/ml
(359561068 pg/ml, n= 16; Fig. 2). Likewise, when grouped based
on urinary NGAL, Robo4 levels were also significantly different
(AKI: 6335 ng/ml, IQR 5025–7771, n= 6; vs non-AKI: 3723 ng/
ml, IQR 2840–5028, p= 0041). When patients were grouped
according to AKIN guidelines, there was a significant difference
(p = 0.003) between AKI (6546 pg/ml, IQR 5025–8079; n= 6)
and non-AKI patients (3727 pg/ml, IQR 1962–3727; n= 26;
Fig. 3).
For comparison, when peak levels of vWF or Ang-2 (see
Table 3) were also grouped according to NGAL and AKIN
criteria; the levels of vWF (2 h) in the .150 ng/ml plasma NGAL
group (163.3648.8%) were significantly higher (p = 0.0042) than
the ,150 ng/ml NGAL group (109.9648.9%). By contrast, vWF
levels were not significantly different when grouped according to
the AKIN definition (data not shown). The reverse was true for 24
h Ang-2 levels, with significantly higher (p = 0.003) levels in the
AKI group, defined using the AKIN definition (9.81 pg/ml, IQR
8.45–12.2 vs. 6.34 pg/ml, IQR 4.49–8.9) but not the plasma
NGAL cut-off definition (data not shown).
Finally, neither duration of mechanical ventilation (16.5 h, IQR
11.5–2.1) nor PF ratio (313.76102.3) associated significantly with
Robo4 levels (data not shown). Likewise, neither pre- nor post-
operative levels of Ang-2 were associated with Robo4 (data not
shown). By contrast, pre-operative Robo4 and vWF levels were
significantly, positively correlated (r = 0.561, r2 = 0.314,
p = 0.0008); as were levels of these biomarkers at 24 h
(r = 0.4895, r2 = 0.2396, p = 0.0045), but not those measured 2 h
post-operatively.
Discussion
We have shown for the first time that the membrane-associated
regulatory protein of endothelial activation, Robo4, is detectable
in plasma of patients undergoing cardiac surgery requiring CPB;
and that levels were raised, 2 h post-operatively, and returned to
baseline by 24 h. Whilst pre-operative Robo4 levels correlated
with pre-operative risk (EUROscore) assessment, there was no
significant difference between groups when patients were classified
as ‘high’ or ‘low’ risk. By contrast, increased plasma Robo4,
measured 2 h post-operatively, did not correlate with operative
variables; post-operative outcomes (level 3 care, ICU and hospital
LOS); indices of pulmonary dysfunction (PF ratio, duration of
mechanical ventilation), or raised levels of conventional plasma
endothelial markers (Ang2 and vWF), also measured at 2 h. Whilst
no associations with pro-inflammatory (IL-6 or -8) cytokines were
demonstrated, there was a positive correlation with levels of the
anti-inflammatory cytokine, IL-10. Raised post-operative plasma
Robo4 levels correlated significantly and positively with plasma
and urine NGAL levels; associations maintained when patients
were divided into those with and without AKI, using an NGAL
cut-off level of 150 ng/ml and also AKIN classification. These
novel findings, suggesting a possible association between raised
plasma Robo4 levels after surgery and AKI, might indicate a
useful, subclinical diagnostic marker of cardiac surgery associated
(CSA)-AKI; and also could point to a possible therapeutic target to
limit this complication.
We (and others) have hypothesised that Robo4 could be a
clinically useful marker of endothelial dysfunction. vWF is
considered the canonical endothelial biomarker. In the current
Table 2. Indices of systemic inflammationa.
Pre-op 2 h post-op 24 h post-op Post-op day 1
CRP
median (IQR) mg/L 2 (1–4) 54 (39.5–70){
WCC mean
mean (SD), 103/ml 7.361.8 8.262.3*
IL-6
median (IQR), pg/ml 19.7 (6.9–35.0) 101.5 (52.9–244)*** 61.1 (33.3–173.2)***
IL-8
median (IQR) pg/ml 4.4 (2.2–6.5) 55.5 (30.3–21)*** 12.7 (6.4–23.2)**, #
IL-10
median (IQR) pg/ml 4.8 (2.3–15.7) 63.7 (40.5–110)*** 32.2 (21.6–47.4)***, #
an = 32 patients undergoing cardiac surgery requiring cardiopulmonary bypass.
CRP, c-reactive protein; WCC, white cell count; IL-6, -8,-10, interleukin-6, -8,-10; IQR = interquartile range, SD= standard deviation.
*p= 0.0378, **p,0.01, ***p,0.001, {p,0.0001, compared with pre-op levels.
#p,0.05, compared with 2 h.
doi:10.1371/journal.pone.0111459.t002
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study the increased levels of vWF detected were similar to those
reported previously, with an increase at 2 h and remaining
elevated at 24 h [9]; decreasing by day 3 [10]. Ang-2 is also a well-
characterised endothelial biomarker, particularly of barrier
function, high levels of which have been reported 24 h after
CPB with levels rising from 2.6 pre to 7.3 ng/ml 24 h post-
operatively [12]; levels very similar to those reported here (2.3 up
to 7.3 ng/ml).
Ang-2 and vWF profiles in this study match those previously
reported; but differed from Robo4 which displayed an early
increase (2 h) and a return to basal levels by 24 h. Whilst limitation
of sample availability precluded a study in all patients at more time
points, a pilot study in 3 patients suggested that Robo4 was
elevated to similar levels immediately after surgery and at 2 h,
decreasing to basal levels by 4 h; implying a rapid rise and fall in
plasma levels. It is possible that this points to rapid cleavage,
followed by clearance of the protein. Raised Robo4 levels 2 h after
surgery requiring CPB did not correlate with post-operative vWF
and Ang-2 levels at this time point, but this does not necessarily
imply that Robo4 is not endothelial-derived. Rapid removal of
Robo4 from the cell surface could possibly act as a first, fast
response to trauma; i.e. to release the protective check on barrier
function. By contrast, more sustained release of vWF or Ang2 from
endothelial Weibel-Palade bodies is characteristic of the ongoing
response to trauma/inflammation. It is also possible that the
association between pre-operative levels of vWF and Robo4
Table 3. Indices of organ dysfunction/injurya.
Pre-op 2 h post-op 24 h post-op Post-op day 1
Kidney
NGAL (plasma) 48.43 150.6 120.2
median (IQR), ng/ml (30.9–65.2) (109.7–193.4)*** (92.68–180.9)***
NGAL (urine) 5.07 15.57 27.95
median (IQR), ng/ml (2.55–11.63) (6.58–123.7)***b (17.65–70.67)***
Creatinine 89.5 86.5
mmol/L median (IQR) (75–111) (76–103.5)
Endothelium
vWF 87.16 136.6 152.9
mean (SD), % (26.8) (55.2)*** (60.5)***
Ang-2 2.32 2.54 7.314
median (IQR), ng/ml (1.89–3.59) (1.92–3.71) (5.38–9.55)***,###
an = 32 patients undergoing cardiac surgery requiring cardiopulmonary bypass; bn = 31.
NGAL, neutrophil gelatinase-associated lipocalin; vWF, von Willibrand Factor; Ang-2, Angiopoeitin-2; IQR = interquartile range, SD= standard deviation.
***p,0.001, compared with pre-op levels; ###p,0.001 compared with 2 h.
doi:10.1371/journal.pone.0111459.t003
Figure 2. Plasma Robo4 levels in patients with or without AKI based on NGAL levels. Plasma levels of Robo4 in patients, 2 h post-cardiac
surgery requiring cardiopulmonary bypass with or without acute kidney injury (AKI); assigned using plasma NGAL cut-off levels of 150 ng/ml. Data
presented as bar graphs with mean and SD concentrations (pg/ml) of Robo4; n = 16 (AKI), n = 16 (non-AKI).
doi:10.1371/journal.pone.0111459.g002
Robo4 and Acute Kidney Injury
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represent continuous, basal turnover of endothelial-associated
molecules. We have unpublished data showing Robo4 was also
detectable in plasma from healthy control volunteers, at levels
similar to those seen in patients’ pre-surgery with CPB, also
perhaps suggestive of on-going Robo4 turnover.
A greater understanding of the mechanism(s) responsible for
increased Robo4 plasma levels, which we are assuming results
from cleavage, could help to shed light on the significance of
plasma Robo4. However, to date, little is known concerning the
release of the ectodomain of any Robo receptor. A recent study
investigated the juxtamembrane domain of Robo1 and showed
that unfolding of the extracellular juxtamembrane linker region
was related to shedding [32]; and others have suggested that the
matrix metalloproteinase, ADAM10, is involved in Robo1
shedding [33].
Whatever the mechanism(s) responsible for an increase in
plasma Robo4; what might the other associations and indeed the
lack of associations, reported in our study point to concerning the
functional significance of Robo4? It is perhaps surprising that
duration from start of anaesthesia to end of CPB did not correlate
with Robo4 levels, given the injurious factors associated with
surgery together with CPB including: activation of blood during
exposure to extra-corporeal circuitry, relative hypo-perfusion,
myocardial and pulmonary ischemia and operative tissue injury
[34]. However, it is of note that unlike our previous study in this
clinical scenario [31], the time recorded was not strictly analogous
to duration of CPB; although it encompassed this parameter and
was employed because of ease of extraction from clinical
databases. We acknowledge this as a limitation to our study. By
contrast, why Robo4 levels positively associated with IL-10 but not
the other cytokines measured, is also unclear. Raised plasma levels
of IL-10, 24 h post-operatively, are predictive of complications
after CPB [35], but whether IL-10 could be responsible for Robo4
shedding is unknown.
Finally, it would appear that the kidney is sensitive to subtle
changes in Robo4 levels (reflected in associations with AKI);
whereas, the lung is not (given the apparent lack of association
with indices of pulmonary dysfunction). Certainly in terms of the
perceived problems associated with this patient group, the need to
understand and to be able to predict and prevent AKI is possibly
more pressing clinically; not least, because the mean PF ratio for
this, albeit small number of patients, was less than that required to
fulfil the criteria for acute lung injury [36]. By contrast, AKI
assumes prognostic significance in this patient group, as we and
others have shown [4,5]. Moreover, a requirement for biomarkers
that can be used to make subclinical diagnoses of CSA-AKI and
thus allow interventions before acute tubular necrosis has already
occurred, are of importance in this clinical specialty [4,5]; and
beyond, not least, given the understanding that AKI and chronic
kidney disease are interconnected syndromes [37].
We have shown a significantly increased level of plasma Robo4
in patients deemed to have AKI, not only using the more
conservative AKIN classification based on serum creatinine levels,
but also employing the novel AKI plasma and urine biomarker,
NGAL. Measurement of NGAL facilitates early detection of AKI,
2 h post-surgery; a time which also corresponds to peak plasma
Robo4 levels. Our novel finding suggests that Robo4 merits
further consideration as a potential early indicator of AKI. Further
support that Robo4 might not be just a coincidental biomarker of
AKI but point to a functional role, is acknowledged through its
endothelial barrier regulatory function [38]. Given that one of the
few currently effective renoprotective agents, nesiritide, protects
against endothelial barrier dysfunction [39]; also points to
endothelial protective strategies to limit CSA-AKI. In conclusion,
Robo4 merits further investigation both as an endothelial
biomarker and as a target for new pharmacological therapeutic
interventions.
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Figure 3. Plasma Robo4 levels in patients with or without AKI according to AKI Network classification. Plasma levels of Robo4 in
patients, 2 h post-cardiac surgery requiring cardiopulmonary bypass with or without acute kidney injury (AKI); assigned according to AKI Network
clinical classification. Data presented as median, IQR concentrations (pg/ml) of Robo4 (n = 26, non-AKI and n= 6, AKI).
doi:10.1371/journal.pone.0111459.g003
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